Koyfin Home > Directory > Health Care > Amphastar Pharma > EBITDA

Amphastar Pharma EBITDA Chart (AMPH)

Amphastar Pharma annual/quarterly EBITDA from 2014 to 2018. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Amphastar Pharma EBITDA for the quarter ending December 12, 2018 was $6m a 196.48% increase of 11m year over year
  • Amphastar Pharma EBITDA for the last 12 months ending December 12, 2018 was $8m a 49.00% increase of 4m year over year
  • Amphastar Pharma Annual EBITDA for 2018 was $8m a -56.32% decrease of -4m from 2017
  • Amphastar Pharma Annual EBITDA for 2017 was $12m a -159.46% decrease of -19m from 2016
  • Amphastar Pharma Annual EBITDA for 2016 was $31m a 68.51% increase of 21m from 2015
Other Income Statement Metrics:
  • Amphastar Pharma Net Income for the quarter ending December 12, 2018 was $2m a 488.11% increase of 9m year over year
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
View Chart On Koyfin

Quarterly AMPH EBITDA Data

12/2018$6m
09/2018$7m
06/2018$1m
03/2018$-5m
12/2017$2m
09/2017$1m
06/2017$6m
03/2017$3m
12/2016$-1m
09/2016$10m

Annual AMPH EBITDA Data

2018$8m
2017$12m
2016$31m
2015$10m
2014$-4m
2013$31m